Lv6
1620 积分 2023-08-14 加入
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
11小时前
已完结
Elucidating Binding Selectivity in Cyclin-Dependent Kinases (CDKs) 4, 6, and 9: Development of Highly Potent and Selective CDK4/9 Inhibitors
1个月前
已完结
The emerging mechanisms of isoform-specific PI3K signalling
1个月前
已完结
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in China
2个月前
已完结
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates
2个月前
已完结
Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy
3个月前
已完结
Gastric cancer
3个月前
已完结
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
3个月前
已完结
State-dependent inhibition of Nav1.8 channels by VX-150 and VX-548
4个月前
已完结
Implementation of digital health technology in clinical trials: the 6R framework
4个月前
已完结
皖公网安备34019202002308
